Commercial Scale Up and Financials Report
Overview Market Opportunity
Product Line & Evidence Commercial Scale Up Insurance Reimbursement Financials
myomo
my own motion
P&L and Key Balance Sheet Metrics
P&L
Key Balance Sheet Metrics
($000's)
Product Revenue
License Revenue
Total Revenue
COGS
Actual
Actual
Q3'23
Q3'22
Actual
2022
Actual
2021
Actual
Actual
($000's)
Q3'23
Q2'23
$ 5,030 $
3,968
50
$ 14,555 $ 13,856
1,000
Cash & Investments
$
11,120
$
8,956
5,080
3,968
15,555
13,856
Working Capital
10,265
8,293
1,591
1,331
5,302
3,544
Net Book Value
11,023
8,820
3,489
2,637
10,253
10,312
Shares Outstanding
68.7%
66.5%
65.9%
74.4%
35,266
668
*
27,932
668
Gross Profit
Gross Margin
Operating Expenses:
R&D
717
691
2,482
SG&A
4,796
4,765
18,443
Total
5,513
5,456
20,925
2,557
18,023
20,580
Operating Loss
$ (2,024) $ (2,819)
$ (10,672) $ (10,268)
Int income
Other expense
Income Taxes
(112)
(34)
(88)
15
71
22
67
-
46
23
70
89
5
11
49
104
Net Loss
$ (2,029) $ (2,830) $ (10,721) $ (10,372)
Warrants Outstanding
* Includes unexercised pre-funded warrants
20View entire presentation